Home/Irazu Oncology/Jeff Strovel, PhD

JS

Jeff Strovel, PhD

Chief Executive Officer

Therapeutic Areas

Irazu Oncology Pipeline

Drug	Indication	Phase
IRZ-01	Solid Tumors (Colorectal, Endometrial, Gastric cancers)	Pre-clinical

Leadership Team at Irazu Oncology

Marcio Chedid, PhD

Chief Scientific Officer

Mayukh Das, MBBS

Chief Medical Officer

Kevin Chen, PhD

Director of Research

Director of Immunology

View full Irazu Oncology profile